{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:32:47Z","timestamp":1782351167711,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","award":["OBS16379"],"award-info":[{"award-number":["OBS16379"]}],"id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","award":["GPP 2022"],"award-info":[{"award-number":["GPP 2022"]}],"id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.rmed.2026.108750","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:21:20Z","timestamp":1772558480000},"page":"108750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Real-world, long-term effectiveness of dupilumab treatment in patients with severe asthma: 2 years of the ProVENT study"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9305-9348","authenticated-orcid":false,"given":"Marek","family":"Lommatzsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Timmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Gappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Watz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Kwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7570-8942","authenticated-orcid":false,"given":"Olivier","family":"Ledanois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Nischan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Korn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10335","key":"10.1016\/j.rmed.2026.108750_bib2","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(22)00331-2","article-title":"Disease-modifying anti-asthmatic drugs","volume":"399","author":"Lommatzsch","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmed.2026.108750_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MCP.0000000000001068","article-title":"Remission in asthma","volume":"30","author":"Lommatzsch","year":"2024","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmed.2026.108750_bib4","article-title":"Roads to remission: evolving treatment concepts in type 2 inflammatory diseases","volume":"80","author":"Lommatzsch","year":"2025","journal-title":"Clin. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108750_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(23)00415-0","article-title":"Pioneering a paradigm shift in asthma management: remission as a treatment goal","volume":"12","author":"Lommatzsch","year":"2024","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.108750_bib6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2026.108750_bib7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jaip.2024.01.044","article-title":"Targeting asthma remission as the next therapeutic step toward improving disease control","volume":"12","author":"Busse","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"1","key":"10.1016\/j.rmed.2026.108750_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S2213-2600(24)00304-7","article-title":"Asthma remission: a call for a globally standardised definition","volume":"13","author":"Lommatzsch","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108750_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(24)00293-5","article-title":"Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis","volume":"13","author":"Shackleford","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2026.108750_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.851940","article-title":"Interleukins 4 and 13 in asthma: key pathophysiologic cytokines and druggable molecular targets","volume":"13","author":"Pelaia","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"14","key":"10.1016\/j.rmed.2026.108750_bib11","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1073\/pnas.1324022111","article-title":"Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice","volume":"111","author":"Murphy","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"5","key":"10.1016\/j.rmed.2026.108750_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/1744666X.2017.1298443","article-title":"Commonality of the IL-4\/IL-13 pathway in atopic diseases","volume":"13","author":"Gandhi","year":"2017","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2026.108750_bib13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation","volume":"75","author":"Le Floc'h","year":"2020","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2026.108750_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.14611","article-title":"Dupilumab is effective in type 2-high asthma patients receiving high-dose inhaled corticosteroids at baseline","volume":"76","author":"Bourdin","year":"2021","journal-title":"Allergy"},{"issue":"26","key":"10.1016\/j.rmed.2026.108750_bib15","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108750_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd4624","article-title":"Targeting key proximal drivers of type 2 inflammation in disease","volume":"15","author":"Gandhi","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"26","key":"10.1016\/j.rmed.2026.108750_bib17","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108750_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000535390","article-title":"Real-world characteristics of patients with severe asthma prior to starting dupilumab: the ProVENT study","volume":"103","author":"Korn","year":"2024","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.rmed.2026.108750_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/jpm15020043","article-title":"Dupilumab effectiveness in patients with severe allergic asthma non-responsive to omalizumab","volume":"15","author":"Bagnasco","year":"2025","journal-title":"J. Personalized Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108750_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.anai.2023.11.006","article-title":"Real-world effectiveness of dupilumab in patients with asthma: findings from the US ADVANTAGE study","volume":"132","author":"Blaiss","year":"2024","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2026.108750_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.chest.2023.10.046","article-title":"Clinical response and remission in patients with severe asthma treated with biologic therapies","volume":"165","author":"Hansen","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.108750_bib24","unstructured":"A. Renner, S. Stoshikj, E. Hamelmann, D. Skowasch, C. Schulz, M. Jandi, et al. Dupilumab Improves long-term Asthma Control in German Patients with Severe Asthma: Real-World Data. Unpublished results."},{"key":"10.1016\/j.rmed.2026.108750_bib25","unstructured":"A.J. Peters , et al. Dupilumab Efficacy and Safety from 12 Months of real-world Asthma Registry Data Unpublished Results."},{"key":"10.1016\/j.rmed.2026.108750_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.107058","article-title":"Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: a real-world Dutch cohort study","volume":"206","author":"Thelen","year":"2023","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108750_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaip.2024.10.009","article-title":"Dupilumab induces long-term on-treatment clinical remission in patients with type 2 asthma","volume":"13","author":"Pavord","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"3 Suppl","key":"10.1016\/j.rmed.2026.108750_bib29","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaci.2011.12.986","article-title":"Asthma outcomes: pulmonary physiology","volume":"129","author":"Tepper","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2026.108750_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7525-3-58","article-title":"Modification of the asthma quality of life questionnaire (standardised) for patients 12 years and older","volume":"3","author":"Juniper","year":"2005","journal-title":"Health Qual. Life Outcome"},{"issue":"1","key":"10.1016\/j.rmed.2026.108750_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S2213-2600(21)00322-2","article-title":"Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study","volume":"10","author":"Wechsler","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.108750_bib32","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/all.16590","article-title":"Clinical and biological remission with tezepelumab: the real-world response in severe uncontrolled asthma","author":"Gates","year":"2025","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.rmed.2026.108750_bib33","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jaip.2024.05.052","article-title":"Real-World data on tezepelumab in patients with severe asthma in Germany","volume":"12","author":"Biener","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126001186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126001186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:40:33Z","timestamp":1775306433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126001186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":29,"alternative-id":["S0954611126001186"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108750","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world, long-term effectiveness of dupilumab treatment in patients with severe asthma: 2 years of the ProVENT study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108750"}}